A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
14 Mar 2023: Trial registered, NCT05768139
17 Apr 2023: Trial started, NCT05768139
The trials
NCT05768139: First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
State
Under way
Phase
Phase 1 and Phase 2
People
880 planned
Started
17 Apr 2023
Primary completion
Jul 2030
Arms
Dose Selection/Expansion Combination
Results
None posted
14 Mar 2023: Trial registered
17 Apr 2023: Trial started
How the status changed
19 Nov 2026: First set: Phase 1 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.